MAPK14 and hepatocellular carcinoma: Two HCC cell lines, Bel-7402 and SMM-7721, which have been described in our previous studies [17-18], were utilized to test cell proliferation activities by using EX527 and SB203580, a well-established SIRT1 and p-p38 inhibitor, respectively.